Financial statements Anpharm Przedsiębiorstwo Farmaceutyczne
Cash flow statement of Anpharm Przedsiębiorstwo Farmaceutyczne
Company age:
Age:
24 y. 3 m. 6 d.
Share capital:
Share capital:
7 561 998 PLN
Cash inflows of ANPHARM PRZEDSIĘBIORSTWO FARMACEUTYCZNE
|
Year
|
2017
|
2018
|
2019
|
2020
|
2021
|
|---|---|---|---|---|---|
| Net cash from operating expenses | 58 429,00 | 52 048 383,24 | 27 732 725,49 | 19 734 828,16 | -9 094 668,33 |
| Net cash flow from investing activities | -7 824,00 | -12 097 406,56 | -12 815 202,21 | -12 239 449,73 | -22 720 194,56 |
| Net cash flow from financial activities | -34 725,00 | -34 725 451,20 | 0,00 | -34 725 451,20 | -9 865 185,00 |
| Total net cash flow | 15 880,00 | 5 225 525,48 | 14 917 523,28 | -27 230 072,77 | -41 680 047,89 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.